Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature

Cancer. 2022 Jan 1;128(1):14-19. doi: 10.1002/cncr.33893. Epub 2021 Sep 8.

Authors

Georges Mjaess^{1

2}, Aya Karam², Fouad Aoun^{2

3}, Simone Albisinni¹, Thierry Roumeguère^{1

3}

Affiliations

¹ Department of Urology, University Clinics of Brussels, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
² Hotel-Dieu de France, University of Saint Joseph, Beirut, Lebanon.
³ Department of Urology, Institut Jules Bordet, Brussels, Belgium.

PMID: 34494666
DOI: 10.1002/cncr.33893

No abstract available

Keywords: fecal microbiota transplantation; immune checkpoint inhibitors; prostate cancer; renal cell carcinoma; urothelial carcinoma.

MeSH terms

Carcinoma, Renal Cell*
Fecal Microbiota Transplantation
Humans
Immunotherapy
Kidney Neoplasms*
Urologic Neoplasms* / therapy